Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medizinska AkadfiledCriticalMedizinska Akad
Priority to BG9199290ApriorityCriticalpatent/BG51485A1/en
Publication of BG51485A1publicationCriticalpatent/BG51485A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The agent is used for treatment of infections in the eye and for preliminary treatment before surgical intervention. The water solution is highly stable, has enhanced efficiency and good physiological endurability. The agent is on the basis of 1-/p-chlorine-benzoil/5-metoxi-2-methylindole-3-tartaric acid, polyoxiethylene/20/sorbitan-monooleate, stabilizing substances and a buffer, which additionally contains propyleneglycol and high-molecular polyethylene oxide with m.m. 5x10<5> to 5x10<6>.
Medical preparations with stomach protecting effect containing n-benzyl-n-/(1s, 5s)-6,6-dimethyl-bicyclo/3.1.1/hept-2-yl-etoxy-ethyl/-morpholinium salts